Published in Crit Care Med on June 01, 2014
ROS-Mediated NLRP3 Inflammasome Activity Is Essential for Burn-Induced Acute Lung Injury. Mediators Inflamm (2015) 0.83
Impaired Immune Response in Elderly Burn Patients: New Insights Into the Immune-senescence Phenotype. Ann Surg (2016) 0.80
Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway. Sci Rep (2015) 0.78
Postburn Hypermetabolism: Past, Present, and Future. J Burn Care Res (2016) 0.78
Threshold age and burn size associated with poor outcomes in the elderly after burn injury. Burns (2016) 0.77
White Adipose Tissue Browning: A Double-edged Sword. Trends Endocrinol Metab (2016) 0.76
Alternative mechanism for white adipose tissue lipolysis after thermal injury. Mol Med (2015) 0.76
Inability to replete white adipose tissue during the recovery phase of sepsis is associated with increased autophagy, apoptosis and proteasome activity. Am J Physiol Regul Integr Comp Physiol (2017) 0.75
Remote inflammatory and metabolic impact of acute injury. Crit Care Med (2014) 0.75
The biochemical alterations underlying post-burn hypermetabolism. Biochim Biophys Acta (2017) 0.75
The inflammasomes. Cell (2010) 19.37
A role for mitochondria in NLRP3 inflammasome activation. Nature (2010) 13.21
Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol (2009) 9.24
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med (2011) 8.00
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol (2011) 6.53
The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med (2012) 5.63
The NLRP3 inflammasome: a sensor for metabolic danger? Science (2010) 4.33
Pathophysiologic response to severe burn injury. Ann Surg (2008) 3.73
The inflammasome: an integrated view. Immunol Rev (2011) 3.52
Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A (2011) 2.92
Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology (2006) 2.82
Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol (2010) 2.61
A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Nat Immunol (2012) 2.59
Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One (2011) 2.58
Association of hyperglycemia with increased mortality after severe burn injury. J Trauma (2001) 2.55
High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes (2003) 2.14
Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery (2008) 2.00
Burn size determines the inflammatory and hypermetabolic response. Crit Care (2007) 1.97
High glucose induces IL-1beta expression in human monocytes: mechanistic insights. Am J Physiol Endocrinol Metab (2007) 1.85
Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes (2007) 1.74
Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab (2009) 1.71
NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol (2011) 1.69
Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med (2002) 1.66
Mitochondria: Sovereign of inflammation? Eur J Immunol (2011) 1.64
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol (2011) 1.56
Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med (2010) 1.53
The inflammasome puts obesity in the danger zone. Cell Metab (2012) 1.49
Deregulated inflammasome signaling in disease. Immunol Rev (2011) 1.39
The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep (2011) 1.39
Postburn trauma insulin resistance and fat metabolism. Am J Physiol Endocrinol Metab (2007) 1.35
Mitochondrial ROS fuel the inflammasome. Cell Res (2011) 1.26
The hypermetabolic response to burn injury and interventions to modify this response. Clin Plast Surg (2009) 1.20
Inflammasome activation in obesity-related inflammatory diseases and autoimmunity. Discov Med (2011) 1.08
Inflammasomes bridge signaling between pathogen identification and the immune response. Drugs Today (Barc) (2009) 1.08
Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch Surg (2004) 1.08
The inflammasome and caspase-1 activation: a new mechanism underlying increased inflammatory activity in human visceral adipose tissue. Endocrinology (2011) 1.04
Endoplasmic reticulum stress and insulin resistance post-trauma: similarities to type 2 diabetes. J Cell Mol Med (2012) 0.87
Metabolic syndrome: is Nlrp3 inflammasome a trigger or a target of insulin resistance? Circ Res (2011) 0.86
Metabolomic analysis of thermally injured and/or septic rats. Burns (2010) 0.84
Role of non-muscle myosin light chain kinase in neutrophil-mediated intestinal barrier dysfunction during thermal injury. Shock (2012) 0.79
[Secondary hyperuricemia in burn and trauma]. Nihon Rinsho (2003) 0.78
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity (2002) 8.17
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med (2007) 6.55
Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat Immunol (2005) 3.51
Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat Immunol (2004) 3.33
Zoned out: functional mapping of stromal signaling microenvironments in the thymus. Annu Rev Immunol (2007) 2.98
Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity (2004) 2.84
Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med (2004) 2.58
Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med (2010) 2.51
Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity (2007) 2.51
Cytokine expression profile over time in severely burned pediatric patients. Shock (2006) 2.33
Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. J Immunol (2004) 2.18
gp96, an endoplasmic reticulum master chaperone for integrins and Toll-like receptors, selectively regulates early T and B lymphopoiesis. Blood (2009) 2.07
Cigarettes butts and the case for an environmental policy on hazardous cigarette waste. Int J Environ Res Public Health (2009) 2.05
Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology (2010) 2.00
T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep (2012) 1.99
Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood (2004) 1.98
Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev (2005) 1.98
Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci U S A (2011) 1.98
Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst (2003) 1.89
Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. Immunity (2007) 1.89
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med (2006) 1.85
Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death. J Exp Med (2004) 1.80
HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes. Blood (2012) 1.76
Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity (2012) 1.75
Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation. Int J Radiat Oncol Biol Phys (2007) 1.75
Regulation of thymocyte differentiation: pre-TCR signals and beta-selection. Semin Immunol (2002) 1.75
Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab (2009) 1.71
Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation. Immunity (2006) 1.70
Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med (2008) 1.67
The OP9-DL1 system: generation of T-lymphocytes from embryonic or hematopoietic stem cells in vitro. Cold Spring Harb Protoc (2009) 1.66
The thymus as an inductive site for T lymphopoiesis. Annu Rev Cell Dev Biol (2007) 1.64
Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med (2007) 1.62
CH3NH3PbI3 perovskite/fullerene planar-heterojunction hybrid solar cells. Adv Mater (2013) 1.60
The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg (2006) 1.60
Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience. Int J Radiat Oncol Biol Phys (2007) 1.60
Serum cytokine differences in severely burned children with and without sepsis. Shock (2007) 1.59
The leading causes of death after burn injury in a single pediatric burn center. Crit Care (2009) 1.59
Benchmarking outcomes in the critically injured burn patient. Ann Surg (2014) 1.58
Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med (2002) 1.58
Emerging infections in burns. Surg Infect (Larchmt) (2009) 1.57
Application of highly ordered TiO2 nanotube arrays in flexible dye-sensitized solar cells. ACS Nano (2008) 1.57
Body composition changes with time in pediatric burn patients. J Trauma (2006) 1.49
A genomic score prognostic of outcome in trauma patients. Mol Med (2009) 1.48
Thoracic spinal cord stimulation improves cardiac contractile function and myocardial oxygen consumption in a porcine model of ischemic heart failure. J Cardiovasc Electrophysiol (2011) 1.45
Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent. Immunity (2009) 1.43
Retinol binding protein: marker for insulin resistance and inflammation postburn? JPEN J Parenter Enteral Nutr (2011) 1.41
Direct comparison of Dll1- and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes. J Immunol (2010) 1.37
Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study. Lancet (2012) 1.36
A review of gene and stem cell therapy in cutaneous wound healing. Burns (2008) 1.34
Characterization of the inflammatory response during acute and post-acute phases after severe burn. Shock (2008) 1.34
Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann Surg (2005) 1.34
Analysis of factorial time-course microarrays with application to a clinical study of burn injury. Proc Natl Acad Sci U S A (2010) 1.33
Insulin resistance postburn: underlying mechanisms and current therapeutic strategies. J Burn Care Res (2008) 1.30
Long-term propranolol use in severely burned pediatric patients: a randomized controlled study. Ann Surg (2012) 1.30
Upper airway mucus deposition in lung tissue of burn trauma victims. Shock (2008) 1.30
Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate. J Exp Med (2006) 1.29
Notch signaling requires GATA-2 to inhibit myelopoiesis from embryonic stem cells and primary hemopoietic progenitors. J Immunol (2006) 1.29
Cytokine expression profile over time in burned mice. Cytokine (2008) 1.28
Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors. Proc Natl Acad Sci U S A (2008) 1.26
Mechanism and activity of ruthenium olefin metathesis catalysts: the role of ligands and substrates from a theoretical perspective. J Am Chem Soc (2004) 1.25
Large-scale multiplexed quantitative discovery proteomics enabled by the use of an (18)O-labeled "universal" reference sample. J Proteome Res (2009) 1.24
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nat Biotechnol (2008) 1.24
A survival guide to early T cell development. Immunol Res (2006) 1.24
Evolution of the Ly49 and Nkrp1 recognition systems. Semin Immunol (2008) 1.24
Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys (2008) 1.23
Age-dependent differences in survival after severe burns: a unicentric review of 1,674 patients and 179 autopsies over 15 years. J Am Coll Surg (2006) 1.23
Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. Blood (2009) 1.22
The basic helix-loop-helix transcription factor HEBAlt is expressed in pro-T cells and enhances the generation of T cell precursors. J Immunol (2006) 1.21
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys (2005) 1.21
Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev (2010) 1.20
Electron transport and recombination in solid-state dye solar cell with spiro-OMeTAD as hole conductor. J Am Chem Soc (2009) 1.20
The hypermetabolic response to burn injury and interventions to modify this response. Clin Plast Surg (2009) 1.20
Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. Radiother Oncol (2011) 1.19
T-cell development, doing it in a dish. Immunol Rev (2006) 1.18
Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice. Am J Respir Cell Mol Biol (2005) 1.17
Three-dimensional architecture of the thymus is required to maintain delta-like expression necessary for inducing T cell development. J Immunol (2006) 1.17
Chromosome transfer activates and delineates a locus control region for perforin. Immunity (2007) 1.16
The role of radiation in the treatment of advanced juvenile angiofibroma. Laryngoscope (2002) 1.16
Severe burn-induced endoplasmic reticulum stress and hepatic damage in mice. Mol Med (2009) 1.16
Are serum cytokines early predictors for the outcome of burn patients with inhalation injuries who do not survive? Crit Care (2008) 1.15
Propensity of adult lymphoid progenitors to progress to DN2/3 stage thymocytes with Notch receptor ligation. J Immunol (2005) 1.15
Extent and magnitude of catecholamine surge in pediatric burned patients. Shock (2010) 1.15
Post-burn hepatic insulin resistance is associated with endoplasmic reticulum (ER) stress. Shock (2010) 1.13
Mechanism-based design of a ROMP catalyst for sequence-selective copolymerization. Angew Chem Int Ed Engl (2005) 1.12
Occurrence of multiorgan dysfunction in pediatric burn patients: incidence and clinical outcome. Ann Surg (2014) 1.12
In vitro generation of T lymphocytes from embryonic stem cell-derived prehematopoietic progenitors. Blood (2003) 1.12
Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Arch Neurol (2006) 1.11
Nickel oxide electrode interlayer in CH3 NH3 PbI3 perovskite/PCBM planar-heterojunction hybrid solar cells. Adv Mater (2014) 1.11
Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition. Cancer Res (2010) 1.11
Determining γδ versus αß T cell development. Nat Rev Immunol (2010) 1.09
Treatment of second degree facial burns with allografts--preliminary results. Burns (2005) 1.09
Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs. J Am Coll Surg (2009) 1.09
IGF-1 protects intestinal epithelial cells from oxidative stress-induced apoptosis. J Surg Res (2006) 1.09
T-cell potential and development in vitro: the OP9-DL1 approach. Curr Opin Immunol (2007) 1.08
Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells. Blood (2008) 1.08
Pathophysiology of burns. Wien Med Wochenschr (2009) 1.08
Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs. Infect Immun (2005) 1.07
CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus. J Immunol (2006) 1.06